PDCD1 and non-small cell lung carcinoma: In order to confirm the IFN-γ released from T-cell in cytotoxicity to NSCLC cells, we analyzed IFN-γ release in NSCLC upon the combination treatment with PD-1 mAb and nobiletin (Figure S4).